LDHC and neoplasm: In this respect, we and others have shown that LDHC is expressed in various tumor types, can elicit anti-tumor cellular immune responses, is associated with worse clinical outcomes, and supports tumorigenesis and progression through multiple biological processes [9,10,11,12,13,14,15,17].